147 related articles for article (PubMed ID: 32875492)
1. Double VEGF/HGF Gene Therapy in Critical Limb Ischemia Complicated by Diabetes Mellitus.
Barć P; Antkiewicz M; Śliwa B; Frączkowska K; Guziński M; Dawiskiba T; Małodobra-Mazur M; Witkiewicz W; Kupczyńska D; Strzelec B; Janczak D; Skóra JP
J Cardiovasc Transl Res; 2021 Jun; 14(3):409-415. PubMed ID: 32875492
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Critical Limb Ischemia by pIRES/VEGF165/HGF Administration.
Barć P; Antkiewicz M; Śliwa B; Baczyńska D; Witkiewicz W; Skóra JP
Ann Vasc Surg; 2019 Oct; 60():346-354. PubMed ID: 31200059
[TBL] [Abstract][Full Text] [Related]
3. Clinical Safety and Preliminary Efficacy of Plasmid pUDK-HGF Expressing Human Hepatocyte Growth Factor (HGF) in Patients with Critical Limb Ischemia.
Cui S; Guo L; Li X; Gu Y; Fu J; Dong L; Song H; Chen X; Lu Y; Hu C; Xiao F; Zhu D; Wu Z; Zhang Q
Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):494-501. PubMed ID: 26122834
[TBL] [Abstract][Full Text] [Related]
4. Two-Stage Gene Therapy (VEGF, HGF and ANG1 Plasmids) as Adjunctive Therapy in the Treatment of Critical Lower Limb Ischemia in Diabetic Foot Syndrome.
Barć P; Antkiewicz M; Frączkowska-Sioma K; Kupczyńska D; Lubieniecki P; Witkiewicz W; Małodobra-Mazur M; Baczyńska D; Janczak D; Skóra JP
Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232122
[TBL] [Abstract][Full Text] [Related]
5. Results of 5-year follow-up study in patients with peripheral artery disease treated with PL-VEGF165 for intermittent claudication.
Deev R; Plaksa I; Bozo I; Mzhavanadze N; Suchkov I; Chervyakov Y; Staroverov I; Kalinin R; Isaev A
Ther Adv Cardiovasc Dis; 2018 Sep; 12(9):237-246. PubMed ID: 29996720
[TBL] [Abstract][Full Text] [Related]
6. The Efficacy of HGF/VEGF Gene Therapy for Limb Ischemia in Mice with Impaired Glucose Tolerance: Shift from Angiogenesis to Axonal Growth and Oxidative Potential in Skeletal Muscle.
Stafeev I IS; Boldyreva MA; Michurina SS; Agareva MY; Radnaeva AV; Menshikov MY; Hu YC; Makarevich PI; Parfyonova YV
Cells; 2022 Nov; 11(23):. PubMed ID: 36497083
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for peripheral arterial disease.
Shimamura M; Nakagami H; Taniyama Y; Morishita R
Expert Opin Biol Ther; 2014 Aug; 14(8):1175-84. PubMed ID: 24766232
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Benefits and Adverse Effects of Combined Proangiogenic Gene Therapy in Mouse Critical Leg Ischemia.
Lebas B; Galley J; Renaud-Gabardos E; Pujol F; Lenfant F; Garmy-Susini B; Chaufour X; Prats AC
Ann Vasc Surg; 2017 Apr; 40():252-261. PubMed ID: 27903483
[TBL] [Abstract][Full Text] [Related]
9. Combined Analysis of Clinical Data on HGF Gene Therapy to Treat Critical Limb Ischemia in Japan.
Morishita R; Shimamura M; Takeya Y; Nakagami H; Chujo M; Ishihama T; Yamada E; Rakugi H
Curr Gene Ther; 2020; 20(1):25-35. PubMed ID: 32416690
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for therapeutic angiogenesis in peripheral arterial disease - a systematic review and meta-analysis of randomized, controlled trials.
Hammer A; Steiner S
Vasa; 2013 Sep; 42(5):331-9. PubMed ID: 23989068
[TBL] [Abstract][Full Text] [Related]
11. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.
Powell RJ; Simons M; Mendelsohn FO; Daniel G; Henry TD; Koga M; Morishita R; Annex BH
Circulation; 2008 Jul; 118(1):58-65. PubMed ID: 18559703
[TBL] [Abstract][Full Text] [Related]
12. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.
Kusumanto YH; van Weel V; Mulder NH; Smit AJ; van den Dungen JJ; Hooymans JM; Sluiter WJ; Tio RA; Quax PH; Gans RO; Dullaart RP; Hospers GA
Hum Gene Ther; 2006 Jun; 17(6):683-91. PubMed ID: 16776576
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy in peripheral artery disease.
Sanada F; Taniyama Y; Kanbara Y; Otsu R; Ikeda-Iwabu Y; Carracedo M; Rakugi H; Morishita R
Expert Opin Biol Ther; 2015 Mar; 15(3):381-90. PubMed ID: 25633211
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial.
Powell RJ; Goodney P; Mendelsohn FO; Moen EK; Annex BH;
J Vasc Surg; 2010 Dec; 52(6):1525-30. PubMed ID: 21146749
[TBL] [Abstract][Full Text] [Related]
15. Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia.
Morishita R; Makino H; Aoki M; Hashiya N; Yamasaki K; Azuma J; Taniyama Y; Sawa Y; Kaneda Y; Ogihara T
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):713-20. PubMed ID: 21183732
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of autologous cell and hepatocyte growth factor gene therapy for neovascularization in a murine model of hindlimb ischemia.
Yamamoto Y; Matsuura T; Narazaki G; Sugitani M; Tanaka K; Maeda A; Shiota G; Sato K; Yoshida A; Hisatome I
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1329-36. PubMed ID: 19666845
[TBL] [Abstract][Full Text] [Related]
17. Effect of High-pressure, Intermittent Pneumatic Compression for the Treatment of Peripheral Arterial Disease and Critical Limb Ischemia in Patients Without a Surgical Option.
Alvarez OM; Wendelken ME; Markowitz L; Comfort C
Wounds; 2015 Nov; 27(11):293-301. PubMed ID: 26574751
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes.
Taniyama Y; Morishita R; Hiraoka K; Aoki M; Nakagami H; Yamasaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Circulation; 2001 Nov; 104(19):2344-50. PubMed ID: 11696476
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia.
Shigematsu H; Yasuda K; Iwai T; Sasajima T; Ishimaru S; Ohashi Y; Yamaguchi T; Ogihara T; Morishita R
Gene Ther; 2010 Sep; 17(9):1152-61. PubMed ID: 20393508
[TBL] [Abstract][Full Text] [Related]
20. Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia.
Shyu KG; Chang H; Wang BW; Kuan P
Am J Med; 2003 Feb; 114(2):85-92. PubMed ID: 12586226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
